TURNING POINT THERAPEUTICS I's ticker is TPTX and the CUSIP is 90041T108. A total of 213 filers reported holding TURNING POINT THERAPEUTICS I in Q2 2022. The put-call ratio across all filers is 3.08 and the average weighting 0.4%.
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Cormorant Asset Management, LP | 2,737,297 | $176,802,000 | 6.75% |
| MPM BioImpact LLC | 308,686 | $19,938,000 | 5.30% |
| Burrage Capital Management LLC | 77,172 | $4,985,000 | 3.49% |
| Orbimed Advisors | 2,745,327 | $177,321,000 | 2.50% |
| Parkman Healthcare Partners LLC | 110,318 | $7,125,000 | 2.01% |
| SECTORAL ASSET MANAGEMENT INC | 284,486 | $18,375,000 | 1.69% |
| First Light Asset Management, LLC | 192,829 | $12,455,000 | 1.45% |
| Asymmetry Capital Management, L.P. | 22,608 | $1,460,000 | 1.12% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 35,000 | $2,236,000 | 0.74% |
| Prosight Management, LP | 25,602 | $1,654,000 | 0.71% |